The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...
JADE201 builds on clinical proof-of-concept for BAFF-R targeting, adding half-life extension technology to provide extended receptor occupancy with the goal of delivering deeper, more durable B cell ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback